Sanofi Withdraws Obesity Pill from FDA Consideration
Faced with an advisory panel that unanimously had safety concerns, Sanofi has decided to withdrawal their NDA for Accomplia (rimonabant).
Sanofi Withdraws Obesity Pill From FDA - Forbes.com:
Sanofi stated they had plans to resubmit the NDA at “a later date”. It should also be noted that Sanofi plans to use the name Zimulti in the US.
It will be interesting to keep an eye on this. I have my own doubts that it will ever get approved in the US.
Technorati Tags: Acomplia, Zimulti, Rimonabant, Sanofi, Sanofi-Aventis
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
